Magellan Rx Management Oncology Biosimilar Answer Provides $40M+ in Annualized Price savings for Early Adopter Overall health Ideas

PHOENIX–(Enterprise WIRE)–Magellan Rx Administration, a division of Magellan Overall health, Inc. (NASDAQ: MGLN), today declared…

PHOENIX–(Enterprise WIRE)–Magellan Rx Administration, a division of Magellan Overall health, Inc. (NASDAQ: MGLN), today declared annualized cost savings of in excess of $40 million for five well being program buyers who ended up early adopters of its oncology biosimilar health care benefit drug management alternative. This complete approach encourages the use of oncology therapeutic biosimilars over additional highly-priced reference products and solutions, when clinically acceptable. Cost savings figures are envisioned to increase even additional as far more shoppers have adopted the application considering the fact that its inception and the market place change to biosimilars accelerates.

“Magellan Rx carries on to be a marketplace chief and disrupter in delivering primary-edge alternatives for the evolving health care landscape, and our health and fitness program partners are recognizing true personal savings by these programs whilst retaining a large excellent amount of care for their customers,” said Steve Cutts, PharmD, senior vice president and standard manager, specialty, Magellan Rx Administration. “We have been monitoring the emergence of biosimilars and begun to deliver biosimilar-first solutions as early as 2016. It is our commitment to being ahead of the craze that has built us a trustworthy lover in medical profit management for virtually two decades.”

Wellness approach shoppers executed the system, which focuses on promotion of biosimilars for three oncology solutions, on or before January 1, 2020. Most of the existing personal savings had been obtained with the initial two merchandise that had biosimilar availability (see graphic), and preliminary effects with the 3rd merchandise are promising. In accordance to Magellan Rx’s internal data, these biosimilars can price payers up to 40% less than their respective reference brands.

“We understood we desired to collaborate with a clinical pharmacy specialist,” explained Carly Rodriguez, pharmacy director at Moda Overall health, a wellness approach that applied the software with achievement. “We were being looking for a companion that would do more than save our strategy on mounting specialty charges, but that would proceed to guidance our associates with Moda’s signature high quality of treatment. In partnering with Magellan Rx, we know we have the appropriate professionals on our side and we anticipate expanding the software to supplemental biosimilar agents, as clinically correct.”

These positive outcomes, after just 1 calendar year, reflect the rising have to have for management packages that deliver reduce most cancers procedure costs for payers and clients while keeping substantial benchmarks of care. Magellan Rx develops expense-productive and top-edge techniques for health care gain drug management throughout a number of types, offering flexible remedies that can also run exterior of the classic payer-PBM marriage. Overall health plans can leverage the substantial clinical know-how and experience at Magellan Rx by delegating specialty and clinical drug management products and services even though retaining a different PBM. Browse a lot more about Magellan Rx’s full specialty drug administration alternatives. To study additional about Magellan Rx Management’s historical past of biosimilar management, stop by, Magellan Insights.

About Magellan Rx Management: Magellan Rx Management, a division of Magellan Health and fitness, Inc., is a next-technology pharmacy group that is delivering meaningful answers to the persons we serve. As pioneers in specialty drug management, marketplace leaders in Medicaid pharmacy packages and disruptors in pharmacy gain management, we companion with our consumers and customers to deliver a finest-in-course healthcare expertise.

About Magellan Health and fitness: Magellan Wellness, Inc. is a chief in controlling the swiftest escalating, most complex places of health, including unique populations, total pharmacy benefits and other specialty places of health care. Magellan supports modern approaches of accessing improved wellbeing by technological know-how, though remaining centered on the critical personal relationships that are necessary to achieve a nutritious, vivid life. Magellan’s prospects include wellness strategies and other managed care corporations, businesses, labor unions, various armed service and governmental organizations and 3rd-occasion administrators. For more info, check out MagellanHealth.com.

(MGLN-GEN)